Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIGNIFY: Ivabradine in stable coronary artery disease
NCT02446990Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2009
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ivabradine in coronary artery disease (CAD), sponsored by Servier. Started Sep 2009; status: completed.
02
Drugs
ivabradine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02446990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446990.